MX2022009473A - Hidrolizado de colageno como principio activo contra la periodontitis o gingivitis. - Google Patents

Hidrolizado de colageno como principio activo contra la periodontitis o gingivitis.

Info

Publication number
MX2022009473A
MX2022009473A MX2022009473A MX2022009473A MX2022009473A MX 2022009473 A MX2022009473 A MX 2022009473A MX 2022009473 A MX2022009473 A MX 2022009473A MX 2022009473 A MX2022009473 A MX 2022009473A MX 2022009473 A MX2022009473 A MX 2022009473A
Authority
MX
Mexico
Prior art keywords
gingivitis
active substance
collagen hydrolysate
substance against
against periodontitis
Prior art date
Application number
MX2022009473A
Other languages
English (en)
Inventor
Stephan Hausmanns
Steffen Oesser
Hans - Ulrich FRECH
Tonja Lipp
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of MX2022009473A publication Critical patent/MX2022009473A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La siguiente invención se refiere a un hidrolizado de colágeno para usarse como principio activo en el tratamiento y/o la profilaxis de la periodontitis o gingivitis.
MX2022009473A 2020-02-18 2020-12-17 Hidrolizado de colageno como principio activo contra la periodontitis o gingivitis. MX2022009473A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102020104279.5A DE102020104279A1 (de) 2020-02-18 2020-02-18 Kollagenhydrolysat als Wirkstoff gegen Parodontitis oder Gingivitis
PCT/EP2020/086865 WO2021164925A1 (de) 2020-02-18 2020-12-17 Kollagenhydrolysat als wirkstoff gegen parodontitis oder gingivitis

Publications (1)

Publication Number Publication Date
MX2022009473A true MX2022009473A (es) 2022-08-22

Family

ID=74181122

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009473A MX2022009473A (es) 2020-02-18 2020-12-17 Hidrolizado de colageno como principio activo contra la periodontitis o gingivitis.

Country Status (11)

Country Link
US (1) US20220387545A1 (es)
EP (1) EP4106869A1 (es)
JP (1) JP2023515440A (es)
KR (1) KR20220143012A (es)
CN (1) CN115279457A (es)
AU (1) AU2020430016A1 (es)
BR (1) BR112022014640A2 (es)
CA (1) CA3168164A1 (es)
DE (1) DE102020104279A1 (es)
MX (1) MX2022009473A (es)
WO (1) WO2021164925A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792202B1 (fr) 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
ITRM20010380A1 (it) 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
JP5732192B2 (ja) * 2009-10-14 2015-06-10 日本ゼトック株式会社 口腔用組成物
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
DK2699249T3 (en) * 2011-04-19 2017-01-09 Bioiberica cartilage Product
DE102011055800A1 (de) * 2011-11-29 2013-05-29 Gelita Ag Verwendung von Kollagenhydrolysat

Also Published As

Publication number Publication date
BR112022014640A2 (pt) 2022-09-13
WO2021164925A1 (de) 2021-08-26
JP2023515440A (ja) 2023-04-13
KR20220143012A (ko) 2022-10-24
CA3168164A1 (en) 2021-08-26
DE102020104279A1 (de) 2021-08-19
US20220387545A1 (en) 2022-12-08
CN115279457A (zh) 2022-11-01
AU2020430016A1 (en) 2022-08-25
EP4106869A1 (de) 2022-12-28

Similar Documents

Publication Publication Date Title
CR20220082A (es) N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos
MXPA05001727A (es) Composiciones y proceso para suministrar un aditivo.
BR0308206A (pt) Composição oral sinergìstica com composto volátil de enxofre para o controle de odor para hálito, e, método para neutralizar sinergisticamente o odor de hálito de composto volátil de enxofre
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
MA39157A1 (fr) Composition utile pour favoriser la fertilite feminine
MX2022003037A (es) Compuestos antibacterianos.
WO2022058147A3 (de) Mittel zur oxidativen farbveränderung von keratinischen fasern mit komplexbildner und aminosäure und/oder proteinhydrolysat
PH12018501060A1 (en) Composition for preventing or treating hair loss comprising chemokine (c-x-c motif) ligand 1 (cxcl1) protein
MX2023006611A (es) Acido hidroxiestearico para inducir la generacion de peptidos antimicrobianos.
MX2023010948A (es) Compuestos antibacterianos.
MX2023010941A (es) Compuestos antibacterianos.
MX2022009473A (es) Hidrolizado de colageno como principio activo contra la periodontitis o gingivitis.
MX2021005163A (es) Formulacion aerosolizable.
AR037420A1 (es) Una composicion acuosa para el tratamiento del cabello, uso de la misma y un metodo para tratar el cabello que emplea a dicha composicion.
WO2020128070A3 (de) Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten
MX2020008511A (es) Composicion antimicrobiana tixotropica.
PH12017502039A1 (en) Oral care device
MY200739A (en) Compositions comprising amino acids for use in the treatment of obesity
MX2022010745A (es) Colageno tipo ii sin desnaturalizar en aplicaciones de alimentos y bebidas y usos de este.
MX2023009041A (es) Uso de inhibidores del proteasoma en el tratamiento de infecciones por coronavirus.
MX2022010859A (es) Colageno tipo ii sin desnaturalizar en alimentos y golosinas para animales.
MX2022003816A (es) Compuestos antibacterianos.
MX2022003814A (es) Compuestos antibacterianos de 4-quinolinona.
DOP2019000222A (es) Composición para retrasar y matizar las canas restaurando el color natural del cabello canoso y dañado.
SG10201805763XA (en) Pharmaceutical composition for preventing or treating hair loss comprising chemokine (c-x-c motif) ligand 1 (cxcl1) protein and minoxidil as active ingredient